Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-02-05

FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat major depressive disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAROXETINE HYDROCHLORIDE (Paroxetine hydrochloride)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE HYDROCHLORIDE)